
Danaher Corporation DHR
€ 148.86
0.02%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation P/CF 2011-2026 | DHR
P/CF Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.3 | 22.7 | 25.6 | 21.3 | 23.4 | 24.9 | 36.4 | 22.7 | 24.7 | 18.9 | 14.5 | 13.9 | 13.1 | 10.7 | 11.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 36.4 | 10.7 | 20.5 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 17.65 | 3.67 % | $ 186 M | ||
|
Agilent Technologies
A
|
28.3 | $ 117.92 | 0.31 % | $ 35.8 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 429.45 | -0.2 % | $ 12.4 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.06 | -19.38 % | $ 376 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.81 | -0.56 % | $ 1.13 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 18.23 | -2.72 % | $ 408 M | ||
|
Natera
NTRA
|
-12.3 | $ 214.17 | 3.58 % | $ 21.1 B | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.04 | 2.23 % | $ 20 B | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Personalis
PSNL
|
-5.62 | $ 5.98 | 7.55 % | $ 354 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 20.87 | 0.82 % | $ 1.11 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 471.04 | 0.93 % | $ 178 B | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.62 | 2.79 % | $ 61.9 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.93 | 1.34 % | $ 692 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 59.92 | 5.68 % | $ 3.58 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 184.9 | -0.26 % | $ 9.16 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Waters Corporation
WAT
|
30.1 | $ 349.35 | 1.92 % | $ 20.8 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 15.16 | 1.74 % | $ 458 M | ||
|
Guardant Health
GH
|
-72.7 | $ 91.12 | 1.78 % | $ 11.4 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 122.9 | 1.3 % | $ 10.1 B | ||
|
Illumina
ILMN
|
19.6 | $ 140.99 | 1.38 % | $ 22.4 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 5.16 | 3.2 % | $ 215 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.2 | 0.51 % | $ 5.05 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 86.08 | 0.3 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 258.55 | 0.55 % | $ 21.5 B | ||
|
Celcuity
CELC
|
-35 | $ 140.36 | -0.94 % | $ 6.56 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.24 | -0.27 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 191.08 | 0.13 % | $ 21.2 B |